Home/Filings/4/0001209191-21-059061
4//SEC Filing

Silva Paul M 4

Accession 0001209191-21-059061

CIK 0001549595other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 5:15 PM ET

Size

5.5 KB

Accession

0001209191-21-059061

Insider Transaction Report

Form 4
Period: 2021-10-01
Silva Paul M
Director
Transactions
  • Award

    Director Stock Option (right to buy)

    2021-10-01+35,00035,000 total
    Exercise: $31.24Exp: 2031-09-30Common Stock (35,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 1/36 of the total shares monthly beginning November 1, 2021 until the option is fully vested on October 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001446372

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:15 PM ET
Size
5.5 KB